samedan logo
home > ict > summer 2020 > speeding clinical trial processes through greater agility
International Clinical Trials

Speeding Clinical Trial Processes Through Greater Agility

Life science organisations, in common with other businesses, are looking urgently towards technology to help them become more agile. Traditional ‘transformational’ projects that take 12-24 months – or even more – are no longer practical as businesses are unlikely to see immediate benefits. In a regulatory context, this is often the case given that global compliance is a moving target. Requirements are continuously being updated and supplemented.

This makes it impractical to try to define all probable needs upfront, then lock down an IT project and go through all the rigorous sequential stages of designing, approving, developing, validating/testing, piloting, and rolling out. By the time that end point comes, there is a strong possibility that needs will have changed and new regulatory requirements will be coming through. This then necessitates a new round of modifications and additions – incurring more delay, cost, and frustration.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the Author

Romuald Braun is VP of Strategy for Life Sciences at Amplexor. He holds a Master’s degree in Drug Regulatory Affairs, an Engineer’s Diploma in Data Technology, and has spent the last 26 years working in compliance, document management, and content management related roles in this industry – in client-based as well as consulting and project management roles.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

• Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up • Tailored upstream development from a single source reduces time to clinic by 20 percent • Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

Pandemic respiratory vaccine clinical trials: a departure from business as usual

ICON plc

Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement